Articles tagged "COVID-19"

2021 American Transplant Congress
Disparities in Living Donor Follow-up During the COVID-19 Emergency Suspension of OPTN Follow-up Reporting Requirements
S. E. Booker, A. Henderson, L. A. Cartwright, S. Taranto, D. Klassen, J. L. Wainright
UNOS, Richmond, VA
*Purpose: The OPTN temporarily suspended follow-up reporting requirements on 4/3/20 (retroactive to 3/13/20) in response to the COVID-19 crisis. We assessed the policy’s impact on…
2021 American Transplant Congress
Covid-19 in Renal Transplant Recipients: Experience of Lithuania
M. Miglinas, M. M. Janušaitė, E. Ašakienė, L. Vareikienė
Nephrology, Vilnius University Santaros clinics, Vilnius, Lithuania
*Purpose: Renal transplant recipients are at increased susceptibility to many viral infections, including coronavirus disease 2019 (COVID-19). The purpose of this review is to define…
2021 American Transplant Congress
Liver Transplantation for COVID-19-associated Cholangiopathy
J. Blondeel¹, P. Meersseman², N. Gilbo¹, I. Jochmans¹, M. Sainz-Barriga¹, J. Pirenne¹, D. Monbaliu¹
¹Abdominal Transplantation Surgery, University Hospitals Leuven, Leuven, Belgium, ²Medical Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium
*Purpose: The hallmark viral pneumonia of coronavirus-19-disease (COVID-19) is often accompanied by important extra-pulmonary manifestations. Liver dysfunction occurs in up to 45% of COVID-19 patients,…
2021 American Transplant Congress
Nurse and Nurse Practitioner-lead Monoclonal Antibody Initiative for Solid Organ Transplant (sot) Recipients with Covid-19
W. Cochran¹, R. Avery², D. Brennan², N. Lawrence², A. Brown², S. Sullivan², B. Adams², M. McCarthy², S. Ellis², F. Naqvi², E. Kraus², N. Alachkar², S. Alasfar², F. Al Ammary², J. Horn², L. Hartman², L. Fessler², S. Purekal², Z. Siddiqui², D. Carter², J. Ficke², M. Kantsiper², L. Boyer², I. Gupta², A. Gurakar², D. Ostrander², J. Langlee², S. Shoham², K. Marr², P. Shah²
¹Johns Hopkins Comprehensive Transplant Center, Baltimore, MD, ²Johns Hopkins, Baltimore, MD
*Purpose: Monoclonal antibody (mAB) infusion (bamlanivimab or casirivimab/imdevimab) for symptomatic, non-hypoxemic, high-risk outpatients with COVID-19 infection, is an available early intervention for COVID-19+ SOT recipients.…
2021 American Transplant Congress
Loneliness in Adults Awaiting Liver Transplantation at 7 U.S. Transplant Centers During the Covid-19 Pandemic
K. Berry¹, D. Kent¹, S. Seetharaman¹, R. Wong¹, Y. Mohamad¹, F. Yao¹, M. Duarte², B. Boyarsky³, R. Rahimi⁴, A. Duarte-Rojo⁵, M. Kappus⁶, M. Volk⁷, D. Ladner⁸, D. Segev³, M. McAdams-DeMarco³, E. Verna⁹, D. Ganger⁸, J. C. Lai¹
¹UCSF, San Francisco, CA, ²Johns Hopkins, Baltimore, CA, ³Johns Hopkins, Baltimore, MD, ⁴Baylor, Dallas, TX, ⁵Pittsburgh, Pittsburgh, PA, ⁶Duke, Durham, NC, ⁷Loma Linda, Loma Linda, CA, ⁸Northwestern, Chicago, IL, ⁹Columbia, New York, NY
*Purpose: Loneliness, defined by the National Academy of Medicine as “a subjective feeling of being isolated”, has recently emerged as a strong predictor of adverse…
2021 American Transplant Congress
Bamlanivimab for Covid-19 in Kidney Transplant Patients
M. Y. Jan, S. El-Sayegh, M. S. Yaqub, D. P. Mishler, O. Adebiyi, M. D. Anderson, T. E. Taber, A. Sharfuddin
Nephrology, Indiana University School of Medicine, Indianapolis, IN
*Purpose: Treatment options for patients with COVID 19 have limited efficacy in reducing severity and duration of viral symptoms as well as progression to severe…